| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Climate change fuels deadly dust storms worldwide
|
Furlow, Bryant
|
|
|
13 |
6 |
p. e32
|
artikel
|
| 2 |
Common and rare variants and survival in idiopathic pulmonary fibrosis
|
Manali, Effrosyni D
|
|
|
13 |
6 |
p. 474-475
|
artikel
|
| 3 |
Effectiveness of nasal high-flow oxygen during apnoea on hypoxaemia and intubation success in paediatric emergency and ICU settings: a randomised, controlled, open-label trial
|
George, Shane
|
|
|
13 |
6 |
p. 545-555
|
artikel
|
| 4 |
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials
|
Amstutz, Alain
|
|
|
13 |
6 |
p. 530-544
|
artikel
|
| 5 |
Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial
|
Ison, Michael G
|
|
|
13 |
6 |
p. 517-529
|
artikel
|
| 6 |
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill
|
Munroe, Elizabeth S
|
|
|
13 |
6 |
p. 556-568
|
artikel
|
| 7 |
Guidelines without borders: the case for JAK inhibitors as the first-line immunomodulator COVID-19 treatment
|
Sweeney, Daniel A
|
|
|
13 |
6 |
p. 478-480
|
artikel
|
| 8 |
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials
|
Meulmeester, Fleur L
|
|
|
13 |
6 |
p. 505-516
|
artikel
|
| 9 |
Inflammatory risks and asthma attacks: what comes next?
|
Al-Ahmad, Mona
|
|
|
13 |
6 |
p. 475-476
|
artikel
|
| 10 |
Nasal high-flow oxygen for apnoeic oxygenation during emergency endotracheal intubation of children
|
Alexander, Emma C
|
|
|
13 |
6 |
p. 480-482
|
artikel
|
| 11 |
Occupational respiratory harms: preventable, not inevitable
|
The Lancet Respiratory Medicine,
|
|
|
13 |
6 |
p. 473
|
artikel
|
| 12 |
Patient in her 70s with COPD and asthma improving significantly since using monoclonal antibody dupilumab
|
Kirby, Tony
|
|
|
13 |
6 |
p. 493-494
|
artikel
|
| 13 |
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation
|
Alonso-González, Aitana
|
|
|
13 |
6 |
p. 495-504
|
artikel
|
| 14 |
The bidirectional complexity of multiple long-term conditions and post-COVID-19 condition
|
Khunti, Kamlesh
|
|
|
13 |
6 |
p. 487-489
|
artikel
|
| 15 |
The big five vexing questions of respiratory syncytial virus immunisation
|
Shaaban, Farina Leonie
|
|
|
13 |
6 |
p. 477-478
|
artikel
|
| 16 |
The passage of Ireland's Human Tissue Act: challenges, consequences, and cross-border cooperation
|
Leonard, Aoife
|
|
|
13 |
6 |
p. 484-487
|
artikel
|
| 17 |
The rising threat of predatory journals and paper mills in respiratory medicine and research
|
Soriano, Joan B
|
|
|
13 |
6 |
p. e30-e31
|
artikel
|
| 18 |
Time T—to understand treatment response
|
Gyselinck, Iwein
|
|
|
13 |
6 |
p. 482-484
|
artikel
|
| 19 |
Transition of adolescents with asthma to adult care
|
Venkatesan, Priya
|
|
|
13 |
6 |
p. 491-492
|
artikel
|
| 20 |
US judge halts Trump's clawback of public health funds
|
Furlow, Bryant
|
|
|
13 |
6 |
p. 490
|
artikel
|
Tijdschrift beschrijving